6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV

Conference Reports for NATAP


6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV Washington, D.C., USA 25-28 October 2004

	Effects of Reyataz & Reyataz+ RTV on Lipids In Vitro by Graeme Moyle MD - (11/12/04) Lipids--the Liver & Heart Disease in HIV by Jacqueline Capeau - (11/12/04) Lipodystrophy Meeting Report: lipoatrophy; facial fillers by Graeme Moyle MD - (11/05/04) Lipoatrophy in HIV: can it be prevented & improved; Risk for Heart Disease in HIV - (10/29/04) Experimental Uridine Therapy for Lipoatrophy - (10/28/04) Insulin Resistance in Healthy Volunteers Taking IDV/rtv & Reyataz/r; TH9507, a new growth hormone releasing fact - (10/27/04)